Irinotecan(CAS: 97682-44-5)

Irinotecan (CAS: 97682-44-5) is a chemotherapy drug belonging to the camptothecin family. It has the chemical formula C23H24N2O5 and is a prodrug that becomes active in the body. Irinotecan works by inhibiting topoisomerase I, an enzyme essential for DNA replication, making it effective against various cancers.

Irinotecan (CAS: 97682-44-5) is primarily used in oncology to treat colorectal cancer, often as part of combination therapy. It also shows efficacy in other malignancies like breast, lung, and pancreatic cancers. As a chemotherapy agent, it is administered intravenously to target rapidly dividing cancer cells.

Irinotecan (CAS: 97682-44-5) is a potent cytotoxic agent and requires strict safety protocols. Its use is regulated by health authorities like the FDA, and safety depends on proper handling by trained professionals. Precautions include wearing protective gear and avoiding exposure to non-occupational individuals due to potential toxicity.

Irinotecan (CAS: 97682-44-5) should be stored in a cool, dry place protected from light. It is typically kept at 2-8°C in tightly sealed containers. Ensure storage away from incompatible substances and follow manufacturer guidelines for stability and shelf life to maintain effectiveness.